Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
Ive had periods when Ive felt that I couldnt accept that I can do the work I do as an academic and wear makeup and enjoy clothes
KellyASAuerbachPBarrientos-PerezMGiesIHalePMMarcusCet alA randomized, controlled trial of liraglutide for adolescents with obesity
Does Levity offer any guarantees for weight loss